Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Jules Miazza"'
Autor:
Jowita Bruno, Mascha Varayath, Brigitta Gahl, Jules Miazza, Caroline E. Gebhard, Oliver T. Reuthebuch, Friedrich S. Eckstein, Martin Siegemund, Alexa Hollinger, David Santer
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Reoperation for bleeding (ROB) after emergency coronary artery bypass grafting (eCABG) has been identified as an independent risk factor for mortality. Consecutively, the influence of fluid intake, fluid output, fluid balance, blood loss, an
Externí odkaz:
https://doaj.org/article/8d454b8a8ae34355a14ab2c5fedc7f80
Autor:
Luca Koechlin, Jules Miazza, Brigitta Gahl, David Santer, Luise Vöhringer, Denis Berdajs, Friedrich S. Eckstein, Oliver Reuthebuch
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
IntroductionThe impact of sex on hospital readmission rate after cardiac surgery is unclear. Therefore, we aimed to analyse sex-specific differences and underlying factors in 30-day readmission rate after cardiac surgery.MethodsWe conducted a single
Externí odkaz:
https://doaj.org/article/01f8c21494cd4f5ba1538205f6902c95
Autor:
Constantin Mork, Simon Adrian Amacher, Brigitta Gahl, Luca Koechlin, Jules Miazza, Thibault Schaeffer, Lena Schmuelling, Jens Bremerich, Denis Berdajs, Nadine Cueni, Michael Kühne, Christian Mueller, Stefan Osswald, Oliver Reuthebuch, Ulrich Schurr, Christian Sticherling, Andrea Kopp Lugli, Stephan Marsch, Hans Pargger, Martin Siegemund, Friedrich Eckstein, Alexa Hollinger, David Santer
Publikováno v:
ESC Heart Failure, Vol 9, Iss 4, Pp 2703-2712 (2022)
Abstract Aims New‐onset atrial fibrillation (NOAF) is the most common complication after cardiac surgery, occurring in 25–50% of patients. It is associated with post‐operative stroke, increased mortality, prolonged hospital length of stay, and
Externí odkaz:
https://doaj.org/article/edbe725b7e9f473bb7f38145633cf0c6
Autor:
Jules Miazza, Ion Vasiloi, Luca Koechlin, Brigitta Gahl, Oliver Reuthebuch, Friedrich S. Eckstein, David Santer
Publikováno v:
Biomedicines, Vol 11, Iss 7, p 1946 (2023)
Due to the advent of interventional therapies for low- and intermediate-risk patients, case complexity has increased in cardiac surgery over the last decades. Despite the surgical progress achieved to keep up with the increase in the number of high-r
Externí odkaz:
https://doaj.org/article/d1f946be41fa402e8f97b2fe4cb00b1e
Autor:
Santer, Jules Miazza, Ion Vasiloi, Luca Koechlin, Brigitta Gahl, Oliver Reuthebuch, Friedrich S. Eckstein, David
Publikováno v:
Biomedicines; Volume 11; Issue 7; Pages: 1946
Due to the advent of interventional therapies for low- and intermediate-risk patients, case complexity has increased in cardiac surgery over the last decades. Despite the surgical progress achieved to keep up with the increase in the number of high-r
Autor:
Denis Berdajs, Jules Miazza, Luca Koechlin, Brigita Gahl, Oliver Reuthebuch, Friedrich Eckstein
Publikováno v:
Canadian Journal of Cardiology.
Publikováno v:
Interdisciplinary CardioVascular and Thoracic Surgery.
Background: Patients refusing blood product transfusion represent a particular cardiac surgery population in which bleedings and hemodilution should be maximally reduced. Case presentation: We present the case of a 60 years old, Jehovah witness patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::27138b47f29cee39c2102b34b55e13d8
https://doi.org/10.21203/rs.3.rs-2004704/v1
https://doi.org/10.21203/rs.3.rs-2004704/v1
Publikováno v:
European Journal of Cardio-Thoracic Surgery. 62
We present the case of a 78-year-old woman suffering from coronary artery disease and secondary severe mitral valve regurgitation due to left ventricular and annular distention. The interdisciplinary heart team recommended a simultaneous hybrid proce
Publikováno v:
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery. 62(2)
A 78-year-old patient underwent his third biological aortic valve replacement (25 mm, Inspiris Resilia™, Edwards Lifesciences LLC, Irvine, CA, USA) with COR-KNOT® (LSI Solutions, Victor, NY, USA) due to valve degeneration in 2018 at a foreign hosp